Cytokinetics (CYTK) Current Leases (2019 - 2026)
Cytokinetics (CYTK) posted quarterly Current Leases of $21.0 million for Q1 2026, up 7.08% year-over-year from $19.6 million in Q1 2025, and up 9.68% quarter-over-quarter from $19.1 million in Q4 2025.
Cytokinetics (CYTK) Current Leases (2019 - 2026) Analysis & Trends
Cytokinetics (CYTK) has reported Current Leases for 8 consecutive years, with $21.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases rose 7.08% year-over-year to $21.0 million; the TTM figure through Mar 2026 stood at $21.0 million (up 7.08% YoY), while the FY2025 annual figure was $19.1 million, up 0.7% from the prior year.
- Current Leases improved to $21.0 million in Q1 2026 per CYTK's latest filing, from $19.1 million in the prior quarter.
- Across five years, Current Leases topped out at $21.0 million in Q1 2026 and bottomed at $12.8 million in Q4 2022.
- Historically, Current Leases has averaged $17.5 million across 5 years, with a median of $18.2 million in 2024.
- On a YoY basis, Current Leases climbed as much as 291.62% in 2022 and fell as far as 13.68% in 2022.
- Cytokinetics' Current Leases stood at $12.8 million in 2022, then soared by 39.46% to $17.9 million in 2023, then increased by 6.08% to $19.0 million in 2024, then increased by 0.7% to $19.1 million in 2025, then grew by 9.68% to $21.0 million in 2026.
- Business Quant data shows CYTK's Current Leases at $21.0 million in Q1 2026, $19.1 million in Q4 2025, and $20.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Cytokinetics | 10.31 Bn | 9.14 Bn | 25.89 Mn | 21.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.04 Mn |
| Mar 31, 2026 | 20.96 Mn |
| Dec 31, 2025 | 19.11 Mn |
| Sep 30, 2025 | 20.65 Mn |
| Jun 30, 2025 | 19.59 Mn |
| Mar 31, 2025 | 19.57 Mn |
| Dec 31, 2024 | 18.98 Mn |
| Sep 30, 2024 | 18.86 Mn |
| Jun 30, 2024 | 18.51 Mn |
| Mar 31, 2024 | 18.23 Mn |
| Dec 31, 2023 | 17.89 Mn |
| Sep 30, 2023 | 17.24 Mn |
| Jun 30, 2023 | 15.70 Mn |
| Mar 31, 2023 | 14.26 Mn |
| Dec 31, 2022 | 12.83 Mn |
| Sep 30, 2022 | 16.06 Mn |
| Jun 30, 2022 | 14.30 Mn |
| Mar 31, 2022 | 14.49 Mn |
| Dec 31, 2021 | 14.86 Mn |
| Sep 30, 2021 | 13.59 Mn |